Tissue Transplantation Products and Services Market

Tissue Transplantation Products and Services
Market - Size, Share, Growth, Outlook, and
Opportunity Analysis, 2018-2026
Chronic diseases often lead to catastrophic damage to vital organs. This damage is usually
irreversible and leads to lifetime dependency on medicines. Under such severe conditions,
transplants remain the mainstay for restoration of healthy life. Globally, there has been a surge in
tissue transplant with advances in medical biotechnology. Tissue transplantation and services market
has seen an increased demand especially from high income countries. Higher prevalence of diseases
such as diabetes, cancer, cardiovascular diseases, renal diseases and Alzheimer’s disease have
post a threat of irreversible tissue damage to a large population globally. According to an article
published in the Journal of Diabetes Care, in 2010, prevalence of diabetes related end stage renal
disease escalated from 17,727 in 1990 to 48,215 in 2006 in the U.S.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/76
Large percentage of cancer patients need to undergo bone marrow transplant. Bone marrow and
peripheral blood stem cell transplantation procedures are essential in restoration of stem cells that
have been destroyed due to high doses of chemotherapy and radiation treatment. According to World
Health Organization, globally, over 14 million new cases and 8.2 million cancer related deaths were
recorded in 2012. Thus, a large target population base exists for companies in the global tissue
transplantation products and services market.
Autologous stem cell transplant has become convenient mainly due to advent of induced
pluripotent stem cells (iPSC). Scientists are trying to develop organs from human induced
pluripotent stem cells (iPSCs). An article published in Nature in 2013, reports the generation of a
functional human organ from pluripotent stem cells. This technique surpasses the risk of
immunosuppression and graft-vs-host disease associated with bone marrow transplant. Although
expensive, the chances of success are higher in case of iPSC transplant procedures. Currently,
the market for tissue transplant products and services is mainly driven by various advancements
in iPSC methods.
Report includes chapters which deeply display the following deliverable about industry :
• Tissue Transplantation Products and Services Market Research Objective and Assumption
• Tissue Transplantation Products and Services Market Purview - Report Description, Executive
Summary, and Coherent Opportunity Map (COM)
• Tissue Transplantation Products and Services Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Tissue Transplantation Products and Services Market, By Regions
• Tissue Transplantation Products and Services Market Competition by Manufacturers including
Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and
Product Type.
• Tissue Transplantation Products and Services Market Manufacturers Profiles/Analysis including
Company Basic Information, Manufacturing Base and Its Competitors.
• Tissue Transplantation Products and Services Market Manufacturing Cost Analysis including Key
Raw Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Tissue Transplantation Products and Services Market Forecast including Production, Consumption,
Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Key Players: Abbott, Biomet, CryoLife, Inc., Arthrex, Exactech, Inc., Celera, Folio
Biosciences, Köhler Chemie, Bristol-Myers, LifeCell Corporation, Centacor and
Novartis.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/76
Global Tissue Transplantation Market Segment
• Based on the Tissue Type
• Cornea
• Heart Valve
•
•
•
•
Skin Grafts
Vascular Grafts
Bone Marrow
Bone Grafts
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Download Report